SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Advaxis, Inc. (ADXS)

Blue you said

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
khaled_shatila Member Profile
 
Followed By 0
Posts 17
Boards Moderated 0
Alias Born 08/28/17
160x600 placeholder
Biotech's Recently Under the Microscope, Analyst Coverage "InvestorsHub NewsWire" - 9/20/2017 8:00:00 AM
Advaxis to Present at Cantor Fitzgerald Global Healthcare Conference "Business Wire" - 9/18/2017 9:02:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 9/11/2017 4:34:01 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/11/2017 4:07:05 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/5/2017 4:31:58 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/5/2017 4:31:58 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/1/2017 4:33:09 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/1/2017 4:32:40 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/21/2017 5:02:24 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 7/12/2017 5:31:49 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/7/2017 6:04:08 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 4:33:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 4:32:55 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/3/2017 4:32:24 PM
Advaxis’ Axalimogene Filolisbac Data Selected for Poster Presentation at ESGO 2017 "Business Wire" - 6/26/2017 8:55:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/20/2017 6:32:13 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/20/2017 6:31:48 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/20/2017 6:31:48 PM
Advaxis to Present at 2017 BIO International Convention "Business Wire" - 6/16/2017 8:00:00 AM
Advaxis to Be Featured on Worldwide Business with kathy ireland® "Business Wire" - 6/14/2017 8:00:00 AM
Advaxis Details Registrational Trials, EU Regulatory and Commercial Plans at Annual Investor & Analyst Day "Business Wire" - 6/13/2017 12:30:00 PM
Advaxis to Webcast Investor & Analyst Day 2017 "Business Wire" - 6/9/2017 8:00:00 AM
Webcast of Advaxis Presentation at Jefferies 2017 Global Healthcare Conference Now Available "Business Wire" - 6/8/2017 9:17:00 AM
Advaxis to Present at Jefferies 2017 Global Healthcare Conference "Business Wire" - 6/7/2017 8:30:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 6/6/2017 5:34:23 PM
khaled_shatila   Wednesday, 09/13/17 10:55:48 PM
Re: blueyedcatch post# 33782
Post # of 35480 
Blue you said

"the company is aware that the news about the Her2 is misinterpreted"

the news about HER2 is NOT misinterpreted, please let them go back to the filing and read how vague it was, it was more misrepresented than misinterpreted.

Having said that i do not believe we will have any appreciation in price as we approach end of year tax related selling i think the shorts will use this as well to put further pressure down (or might be an opportunity for them to cover)

We won't see any rise again until January, Maybe thats why January calls were being heavily bought last two weeks ?

The above guessing about price is in case we don't hear any MAJOR news, PETX approval is not Major
a mega deal or buy out or positive phase 3 that will be only positive news that will move this stock

As for posters at meetings, i personally attend 2 medical conferences every yer, it baffles me why some people on this board think that a poster at a meeting will have ANY effect on price. There are HUNDREDS of posters at these national meetings and they sometimes get no attention from attendees. Late breaking Phase 3 clinical trials is what everybody looks for and attends. Posters are hung in poster areas and people walk around reading titles sometimes stopping at a poster for more than a minute to read. so please lets just be realistic.
- ADXS has excellent potential
- ADXS is heavily manipulated
- ADXS still doesn't have an approved product
- ADXS in my opinion even at this stage (read above) is still undervalued
- ADXS has Excellent potential (i know that was point number one)

Good luck guys

I'm not selling a single share its boom or bust for me ... Who's with me :)


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist